does glp 1 cause insulin resistance The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1: Genetic Variants Related to

As regards antral length, the current results revealed a significant increase in antral length in the patients who received KD with L-carnitine supplementation after intervention in comparison to the time of enrolment, while there was no significant change noticed in the non-supplemented group

However, patients often report feeling more energetic during treatment due to indirect benefits such as weight reduction, improved blood sugar control, and better sleep quality

Liver cancer was defined as primary liver malignancy, including hepatocellular carcinoma, and the term liver cancer is used consistently throughout the manuscript

Subsequently, LEADER and SUSTAIN-6 were reported, which investigated respectively liraglutide and semaglutide vs